MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31.

Income Overview

Net Income
-$5,681K
EPS
-$0.06
Unit: Thousand (K) dollars

Income Statement
2025-12-31
2025-09-30
2025-06-30
General and administrative
2,126 316* 4,500
Research and development
4,656 7,715* 9,959
Total operating expenses
6,782 8,031 14,459
Operating loss
-6,782 -8,031* -14,459
Grant income
--38* 25
Research and development incentive income
33 267* 127
Interest income, net
1,079 1,453* 1,075
Foreign exchange gain (loss)
7 -299* -11
Total other income, net
1,119 1,383* 1,216
Net loss before provision for income taxes
-5,663 --
Income tax expense, current
18 --
Net loss and comprehensive loss
-5,681 -6,648 -13,243
Basic EPS
-0.06 -0.078 -0.16
Diluted EPS
-0.06 -0.078 -0.16
Basic Average Shares
89,029,458 85,198,307 85,380,587
Diluted Average Shares
89,029,458 85,198,307 85,380,587
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss andcomprehensive loss-$5,681K Interest income, net$1,079K Research and developmentincentive income$33K Foreign exchange gain(loss)$7K Net loss beforeprovision for income taxes-$5,663K Income tax expense,current$18K Total other income,net$1,119K Operating loss-$6,782K Total operatingexpenses$6,782K Research and development$4,656K General andadministrative$2,126K

ANAVEX LIFE SCIENCES CORP. (AVXL)

ANAVEX LIFE SCIENCES CORP. (AVXL)